Skip to main content
. 2020 Jan;18(1):179–187.e6. doi: 10.1016/j.cgh.2019.05.013

Figure 3.

Figure 3

Endoscopic IBD response at baseline endoscopy before vedolizumab and after treatment with vedolizumab. Paired endoscopic scores were available for 36 patients for Mayo Endoscopic Subscore, 13 patients for UCEIS, and 5 patients for SES-CD. Individual scores for each patient are shown as black dots, with bars indicating the mean value and the standard deviation is shown. Paired Student t test performed. SES-CD, Simple Endoscopic Score for Crohn’s Disease; UCEIS, Ulcerative Colitis Endoscopic Index of Severity; VDZ, vedolizumab; ns = P > .05; *P ≤ .05; ***P ≤ .001.